1. Home
  2. SIMO vs LQDA Comparison

SIMO vs LQDA Comparison

Compare SIMO & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SIMO
  • LQDA
  • Stock Information
  • Founded
  • SIMO 1995
  • LQDA 2004
  • Country
  • SIMO Hong Kong
  • LQDA United States
  • Employees
  • SIMO N/A
  • LQDA N/A
  • Industry
  • SIMO Semiconductors
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • SIMO Technology
  • LQDA Health Care
  • Exchange
  • SIMO Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • SIMO 2.7B
  • LQDA 2.5B
  • IPO Year
  • SIMO 2005
  • LQDA 2018
  • Fundamental
  • Price
  • SIMO $88.73
  • LQDA $25.99
  • Analyst Decision
  • SIMO Strong Buy
  • LQDA Strong Buy
  • Analyst Count
  • SIMO 8
  • LQDA 9
  • Target Price
  • SIMO $84.38
  • LQDA $32.11
  • AVG Volume (30 Days)
  • SIMO 257.0K
  • LQDA 2.3M
  • Earning Date
  • SIMO 10-29-2025
  • LQDA 11-12-2025
  • Dividend Yield
  • SIMO 2.25%
  • LQDA N/A
  • EPS Growth
  • SIMO N/A
  • LQDA N/A
  • EPS
  • SIMO 2.30
  • LQDA N/A
  • Revenue
  • SIMO $768,738,000.00
  • LQDA $19,322,000.00
  • Revenue This Year
  • SIMO $5.44
  • LQDA $362.31
  • Revenue Next Year
  • SIMO $15.56
  • LQDA $418.29
  • P/E Ratio
  • SIMO $38.72
  • LQDA N/A
  • Revenue Growth
  • SIMO N/A
  • LQDA 30.20
  • 52 Week Low
  • SIMO $37.21
  • LQDA $9.68
  • 52 Week High
  • SIMO $90.50
  • LQDA $29.94
  • Technical
  • Relative Strength Index (RSI)
  • SIMO 71.69
  • LQDA 51.91
  • Support Level
  • SIMO $77.22
  • LQDA $27.15
  • Resistance Level
  • SIMO $90.50
  • LQDA $29.43
  • Average True Range (ATR)
  • SIMO 2.89
  • LQDA 1.24
  • MACD
  • SIMO 0.86
  • LQDA -0.58
  • Stochastic Oscillator
  • SIMO 87.72
  • LQDA 8.25

About SIMO Silicon Motion Technology Corporation

Silicon Motion Technology Corp is engaged in developing NAND flash controllers for SSDs and other solid state storage devices. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: